Chemosphere · 2017 · 733 citations · 33 references
PharmacyEnvironmental SciencesToxicologyEnvironmental ChemistryEnvironmental ToxicologyWastewater TreatmentAquatic Contaminant FateEnvironmental ContaminantsWater PollutionWater QualityAdverse Health EffectsAquatic PollutantsEndocrine Disrupting CompoundsEnvironmental Fate Of ContaminantsEnvironmental Fate Of PollutantsToxic ContaminationWastewater Treatment Processes
for methamphetamine. The related environmental risks are also discussed for some ECs, with particular reference to their ability to disrupt endocrine systems. The current study propose the potential of the pharmaceuticals carbamazepine, naproxen, diclofenac and ibuprofen to be regarded as priority ECs for environmental monitoring due to their regular detection and persistence in environmental waters and their possible contribution towards adverse health effects in humans and wildlife.
33
Barbara Kasprzyk‐Hordern, Richard M. Dinsdale, Alan J. Guwy · Water Research · 2008 · 1.7K citations
Engineering, Environmental Engineering, Environmental Sciences +17
In vitro and in vivo estrogenicity of UV screens.
Margret Schlumpf, Beata Cotton, M Conscience et al. · Environmental Health Perspectives · 2001 · 808 citations · Full text
Pharmacy, Dermatology, Toxicology +11
Adverse Outcome Pathway (AOP) Development I: Strategies and Principles
Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero et al. · Toxicological Sciences · 2014 · 711 citations · Full text